Form 4: Dyadic CEO Extends Convertible Note Maturity to 2027
Beneficial Ownership Change
Dyadic International's CEO, Mark A. Emalfarb, amended a senior secured convertible promissory note, extending its maturity to December 31, 2027, and adjusting the conversion price to $1.05.
Summary
- Mark A. Emalfarb, CEO, Director, and 10% Owner of Dyadic International, Inc. (DYAI), filed a Form 4 reporting a change in beneficial ownership.
- An amendment was made to a Senior Secured Convertible Promissory Note, originally due March 8, 2027.
- The amendment extends the maturity date of the note to December 31, 2027.
- The conversion price of the note was adjusted from $1.40 to $1.05.
- The amendment was approved by the Company's board of directors and did not involve an exchange of consideration between the Company and the holders.
- The note has a principal amount of $1,000,000 and is held indirectly through the Mark A Emalfarb Trust U/A/ DTD 10/1/1987.
- At the original conversion price of $1.40, the note was convertible into 714,286 shares of common stock.
- At the amended conversion price of $1.05, the note is convertible into 952,381 shares of common stock.
Sentiment
Score: 4
Explanation: While the maturity extension offers some relief, the reduction in conversion price is dilutive, indicating a potentially lower valuation perception or a concession made to the noteholder, who is also the CEO and a significant owner.
Positives
- The extension of the maturity date for the convertible note provides the company with more time before repayment or conversion, improving short-term liquidity management.
- The amendment was approved by the Company's board of directors, indicating internal alignment on the terms.
- No exchange of consideration was involved, suggesting the amendment was a mutually beneficial adjustment rather than a new capital outlay for the company.
Negatives
- The conversion price was reduced from $1.40 to $1.05, which is dilutive to existing shareholders if the note is converted, as more shares will be issued for the same principal amount.
- The reduction in conversion price could signal a lower perceived value of the company's stock by the noteholder or the board at the time of the amendment.
Risks
- Potential future dilution for existing shareholders if the convertible note is converted at the lower $1.05 price, as this would result in the issuance of 952,381 shares compared to the original 714,286 shares.
- The company will still face the obligation to repay or convert the note by the new maturity date of December 31, 2027.
Future Outlook
The extension of the convertible note's maturity date to December 31, 2027, provides the company with additional time to manage its capital structure, potentially allowing for future growth or operational improvements before the obligation becomes due.
Management Comments
- The Amendment was approved by the Company's board of directors, and did not involve the exchange of consideration between the Company and the holders.
Industry Context
This type of amendment, extending maturity and adjusting conversion terms for insider-held debt, is common for smaller biotechnology or life sciences companies like Dyadic International, which often rely on convertible debt for financing and may need flexibility in managing their capital structure as they progress through R&D and commercialization phases. The adjustment in conversion price could reflect market conditions or internal valuation perspectives at the time of the amendment.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Debt Instrument Amendment | The Company's board of directors approved an amendment to the Senior Secured Convertible Promissory Note, extending its maturity and adjusting the conversion price. | 12/23/2025 | This change impacts the company's capital structure and potential future dilution, demonstrating board oversight of significant financial instruments involving key executives. |
Related Party Transactions
- The amendment to the Senior Secured Convertible Promissory Note involves Mark A. Emalfarb, the CEO, Director, and 10% Owner of Dyadic International, Inc., through his trust. This constitutes a related party transaction.
Stakeholder Impact
- Shareholders: Potential for increased dilution if the convertible note is converted at the lower $1.05 price, as more shares will be issued for the same debt amount. However, the extension of the maturity date provides the company with more time to improve its financial position before conversion or repayment.
- Creditors (Noteholder): The noteholder (Mark A. Emalfarb's trust) benefits from an extended maturity date and a lower conversion price, making conversion more attractive or providing more time for the company to perform.
- Company: Gains flexibility in managing its debt obligations due to the extended maturity date.
Next Steps
- The company will continue to operate under the terms of the amended Senior Secured Convertible Promissory Note until its new maturity date of December 31, 2027.
Key Dates
| Date | Description |
|---|---|
| 10/01/1987 | Date of Mark A Emalfarb Trust U/A/ DTD 10/1/1987, through which the note is indirectly held |
| 12/23/2025 | Date of the amendment to the Senior Secured Convertible Promissory Note |
| 12/29/2025 | Signature date of the reporting person's attorney-in-fact on the Form 4 |
| 03/08/2027 | Original maturity date of the Senior Secured Convertible Promissory Note |
| 12/31/2027 | New maturity date of the Senior Secured Convertible Promissory Note after the amendment |
Recommendation
holdThe extension of the convertible note's maturity provides some operational flexibility for Dyadic International. However, the reduction in the conversion price from $1.40 to $1.05 is dilutive to existing shareholders, indicating a potential negative signal regarding the company's valuation or a concession to a key insider. Given these mixed signals, a 'hold' recommendation is appropriate, awaiting further clarity on the company's operational performance and strategic direction.
Keywords
Dyadic International, DYAI, SEC Form 4, Convertible Note, Promissory Note, Beneficial Ownership, Mark A Emalfarb, Maturity Extension, Conversion Price, Dilution, Corporate Governance
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.